Baptiste Chevet
Brest, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
What cumulative glucocorticoid dose should trigger sparing strategies in polymyalgia rheumatica?
Journal: Joint bone spine
Published: January 12, 2026
Tapering or stopping tocilizumab in PMR: Toward optimized treatment withdrawal.
Journal: Joint bone spine
Published: November 09, 2025
Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease.
Journal: Annals of the rheumatic diseases
Published: September 24, 2025
Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: December 23, 2024
Clinical presentation and treatment response in ACPA-negative rheumatoid arthritis.
Journal: Joint bone spine
Published: September 11, 2024
The pipeline of immunomodulatory therapies in polymyalgia rheumatica and giant cell arteritis: A systematic review of clinical trials.
Journal: Autoimmunity reviews
Published: May 21, 2024
Recommendations of the French Society of Rheumatology for the management in current practice of patients with polymyalgia rheumatica.
Journal: Joint bone spine
Published: February 17, 2024
Dual MPO/PR3 ANCA positivity and vasculitis: insights from a 7-cases study and an AI-powered literature review.
Journal: Rheumatology (Oxford, England)
Published: November 14, 2023
Efficacy and management of tocilizumab in polymyalgia rheumatica: results of a multicentre retrospective observational study.
Journal: Rheumatology (Oxford, England)
Published: February 03, 2023
Long-Term Opioid Therapy Among Patients With Systemic Lupus Erythematosus in the Community: A Lupus Midwest Network (LUMEN) Study.
Journal: The Journal of rheumatology
Published: October 24, 2022
Last Updated: 09/26/2026